Nonneoplastic Epithelial Disorders of Vulva and High Intensity Focused Ultrasound

Jinan Military General Hospital

Status: Unknown

Conditions: Vulva Intraepithelial Nonneoplastic

Treatments: Device: the high intensity focused ultrasound (Mianyang Sonic electronic LLC); Drug: Fu Tiankang disposable vaginal filling suppository, Albothyl (Policresulen Solution) , and the gynecologic medical antimicrobial dressing gel (chitosan gel).

Study type: Interventional

Funder types: Other

Identifiers

NCT02890277

JNJQ201408

Details and patient eligibility

About

Nonneoplastic epithelial disorders of skin and mucosa of vulva refer to a group of chronic diseases shown as female genital skin and mucosal tissue degeneration and pigmentation change. The main symptoms are vulval itching, squamous cell hyperplasia, vulval and perianal skin atrophy or thinning, hypopigmentation. The current treatments are primarily local drug or surgical treatments. However, the effect is not good enough, but the diseases often recur and severely affect patients' quality of life. In this study, the investigators combined the technology of high intensity focused ultrasound (HIFU) (ultrasound device made by Mianyang Sonic electronic LLC, Mianyang China, registration number: 2005-2230099} with special drug to treat. The data from colposcopy and biopsy pathology were collected before and after treatment to create the objective identifying degree of the disease by with "grading methods" and evaluate the treatment effect. At the meantime, the standardized treatment procedure, methods and efficacy criterion were all stipulated to achieve satisfactory results, which could be used to clinical treatments. So far, the investigators have not seen similar study reported internationally.

Enrollment: 120 estimated patients

Sex: Female

Ages: 18 to 78 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients with clinically and biopsy confirmed non-neoplastic lesions of genital skin and mucous membrane (non-neoplasia epithelial disorders of skin and mucosa of vulva).

Symptoms include repeated itching, discoloration, rhagades, loss of skin elasticity and dyspareunia that affect the patients' quality of life.

Exclusion criteria

• atypical hyperplasia or vulvar cancer confirmed by biopsy of genital lesions;
• vulvovaginal or other gynecological trauma, acute inflammatory diseases and other acute illness in need of urgent care;
• combined with other serious gynecological diseases (symptomatic hysteromyoma, ovarian tumor, etc.), and/or severe organ diseases (such as heart, lung, brain and renal disease/failure) that need immediate treatment;
• other type of cancers that require urgent care.

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

120 participants in 1 patient group

Treatment group

Experimental group

Treatment:

Device: the high intensity focused ultrasound (Mianyang Sonic electronic LLC)

Drug: Fu Tiankang disposable vaginal filling suppository, Albothyl (Policresulen Solution) , and the gynecologic medical antimicrobial dressing gel (chitosan gel).